Alaunos Therapeutics Inc (TCRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 60,392 | 48,839 | 11,379 | 35,029 | 26,856 |
| Marketable Securities | N/A | N/A | N/A | N/A | 1,555 |
| TOTAL | $60,816 | $49,193 | $11,706 | $35,528 | $28,873 |
| Non-Current Assets | |||||
| PPE Net | 253 | 255 | 489 | 746 | 451 |
| Other Non-Current Assets | 451 | 288 | 378 | 453 | 188 |
| TOTAL | $704 | $543 | $867 | $1,199 | $639 |
| Total Assets | $61,520 | $49,736 | $12,573 | $36,727 | $29,512 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,031 | 1,789 | 2,639 | 2,909 | 776 |
| Accrued Expenses | 2,538 | 1,261 | 3,137 | 3,397 | 2,162 |
| TOTAL | $3,612 | $3,095 | $5,776 | $6,306 | $2,938 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 43 | 45 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 27,311 | 18,471 | 0 | 0 | 0 |
| TOTAL | $27,355 | $18,537 | $58 | $51 | $41 |
| Total Liabilities | $30,967 | $21,632 | $5,834 | $6,357 | $2,979 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 439 | 277 | 146 | 142 | 102 |
| Common Shares | 48 | 42 | 22 | 21 | 15 |
| Retained earnings | -123,814 | -91,144 | -85,061 | -59,829 | -33,221 |
| TOTAL | $30,553 | $28,104 | $6,739 | $30,370 | $26,533 |
| Total Liabilities And Equity | $61,520 | $49,736 | $12,573 | $36,727 | $29,512 |